论文部分内容阅读
目的探讨双歧三联活菌片治疗小儿腹泻的临床效果。方法小儿腹泻患儿242例,根据入院的先后顺序将其分为对照组和观察组,各121例。对照组采用常规的对症治疗;观察组在对照组基础上采用双歧三联活菌片进行治疗,对比两组患儿的治疗效果。结果观察组患儿总有效率为95.87%,对照组患儿的总有效率为86.78%,两组患儿治疗效果对比差异具有统计学意义(P<0.05)。结论采用双歧三联活菌片治疗小儿腹泻效果显著,并发症的发生率低,依从性好,非常值得在临床上进行推广。
Objective To investigate the clinical efficacy of bifidobacterium triple inactivated tablet in the treatment of children with diarrhea. Methods A total of 242 children with pediatric diarrhea were divided into control group and observation group according to the order of admission, each of which was 121 cases. The control group was treated with conventional symptomatic treatment. The observation group was treated with bifidobacterium triple live viable tablets on the basis of the control group, and the treatment effect was compared between the two groups. Results The total effective rate was 95.87% in the observation group and 86.78% in the control group. There was significant difference between the two groups in the treatment effect (P <0.05). Conclusion The treatment of diarrhea with bifid triple active viable tablets has obvious effect, low complication rate and good compliance, which is worth to be popularized clinically.